These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 21294328)

  • 1. [Do we correctly manage adult asthma patients in family medicine?].
    Marković BB; Vrdoljak D
    Lijec Vjesn; 2010; 132(11-12):370-5. PubMed ID: 21294328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
    Blanchette CM; Culler SD; Ershoff D; Gutierrez B
    Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advair: combination treatment with fluticasone propionate/salmeterol in the treatment of asthma.
    Nelson HS
    J Allergy Clin Immunol; 2001 Feb; 107(2):398-416. PubMed ID: 11174215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The right tools at the right time.
    Humbert M
    Chest; 2006 Jul; 130(1 Suppl):29S-40S. PubMed ID: 16840366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs and resource use of mild persistent asthma patients initiated on controller therapy.
    Colice GL; Yu AP; Ivanova JI; Hsieh M; Birnbaum HG; Lage MJ; Brewster C
    J Asthma; 2008 May; 45(4):293-9. PubMed ID: 18446593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
    Ye X; Gutierrez B; Zarotsky V; Nelson M; Blanchette CM
    Curr Med Res Opin; 2009 Sep; 25(9):2251-8. PubMed ID: 19622006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective claims study of fluticasone propionate/salmeterol fixed-dose combination use as initial asthma controller therapy in children despite guideline recommendations.
    Friedman HS; Eid NS; Crespi S; Wilcox TK; Reardon G
    Clin Ther; 2009 May; 31(5):1056-63. PubMed ID: 19539106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Add-on therapy options in asthma not adequately controlled by inhaled corticosteroids: a comprehensive review.
    Kankaanranta H; Lahdensuo A; Moilanen E; Barnes PJ
    Respir Res; 2004 Oct; 5(1):17. PubMed ID: 15509300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot study.
    Dupont L; Potvin E; Korn D; Lachman A; Dramaix M; Gusman J; Peché R;
    Curr Med Res Opin; 2005 Jun; 21(6):863-9. PubMed ID: 15969886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to anti-inflammatory treatment for asthma in clinical practice in France.
    Latry P; Pinet M; Labat A; Magand JP; Peter C; Robinson P; Martin-Latry K; Molimard M
    Clin Ther; 2008; 30 Spec No():1058-68. PubMed ID: 18640480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Add-on salmeterol compared to double dose fluticasone in pediatric asthma: a double-blind, randomized trial (VIAPAED).
    Gappa M; Zachgo W; von Berg A; Kamin W; Stern-Sträter C; Steinkamp G;
    Pediatr Pulmonol; 2009 Nov; 44(11):1132-42. PubMed ID: 19824054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommendations for treatment of intermittent mild persistent asthma in children and adolescents.
    Naspitz CK; Cropp GJ
    Pediatr Pulmonol; 2009 Mar; 44(3):205-8. PubMed ID: 19206182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asthma update: Part II. Medical management.
    Mintz M
    Am Fam Physician; 2004 Sep; 70(6):1061-6. PubMed ID: 15456115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.
    Cyr MC; Beauchesne MF; Lemière C; Aaron SD; Blais L
    Ann Pharmacother; 2010 Apr; 44(4):613-22. PubMed ID: 20233915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone.
    Mapel DW; Nelson LS; Lydick E; Soriano J; Yood MU; Davis KJ
    COPD; 2007 Jun; 4(2):127-34. PubMed ID: 17530506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Balancing safety and efficacy in pediatric asthma management.
    Skoner DP
    Pediatrics; 2002 Feb; 109(2 Suppl):381-92. PubMed ID: 11826254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asthmatics able to step down from inhaled corticosteroid treatment without loss of asthma control have low serum eotaxin/CCL11.
    Hoffmann HJ; Nielsen LP; Harving H; Heinig JH; Dahl R
    Clin Respir J; 2008 Jul; 2(3):149-57. PubMed ID: 20298323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the addition of Beta2-agonist tulobuterol patches to inhaled corticosteroid in patients with asthma.
    Hozawa S; Haruta Y; Terada M; Yamakido M
    Allergol Int; 2009 Dec; 58(4):509-18. PubMed ID: 19700936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence-based asthma management.
    Kallstrom TJ
    Respir Care; 2004 Jul; 49(7):783-92. PubMed ID: 15222910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma.
    Delea TE; Hagiwara M; Stanford RH; Stempel DA
    Clin Ther; 2008 Mar; 30(3):560-71. PubMed ID: 18405796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.